PACIFIC BIOSCIENCES CALIF IN's ticker is PACB and the CUSIP is 69404D108. A total of 144 filers reported holding PACIFIC BIOSCIENCES CALIF IN in Q4 2019. The put-call ratio across all filers is 1.55 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,342,175 | -53.3% | 280,500 | -25.7% | 0.02% | -58.1% |
| Q2 2023 | $5,018,090 | +105.0% | 377,300 | +78.5% | 0.04% | +87.0% |
| Q1 2023 | $2,447,294 | +446.9% | 211,338 | +286.4% | 0.02% | +475.0% |
| Q4 2022 | $447,446 | -11.4% | 54,700 | -37.2% | 0.00% | 0.0% |
| Q3 2022 | $505,000 | -65.1% | 87,125 | -69.0% | 0.00% | -88.6% |
| Q4 2019 | $1,445,000 | +3702.6% | 280,960 | +2709.6% | 0.04% | +600.0% |
| Q4 2016 | $38,000 | -87.1% | 10,000 | -76.1% | 0.01% | -92.4% |
| Q2 2016 | $295,000 | +247.1% | 41,859 | +318.6% | 0.07% | +88.6% |
| Q1 2016 | $85,000 | – | 10,000 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Madrone Advisors, LLC | 16,415,933 | $218,331,909 | 38.11% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,015,495 | $26,806,084 | 19.75% |
| Decheng Capital Management III (Cayman), LLC | 1,463,872 | $19,469,498 | 6.11% |
| Iron Triangle Partners LP | 2,400,000 | $31,920,000 | 4.27% |
| Jackson Square Partners, LLC | 8,517,624 | $113,284,399 | 3.30% |
| BOURNE LENT ASSET MANAGEMENT INC | 580,000 | $7,714,000 | 2.69% |
| ARK Investment Management | 26,634,620 | $354,240,443 | 2.34% |
| ARDSLEY ADVISORY PARTNERS LP | 906,000 | $12,049,800 | 2.04% |
| Avidity Partners Management LP | 4,337,400 | $57,687,420 | 2.02% |
| Nikko Asset Management Americas, Inc. | 13,649,948 | $181,271,309 | 1.91% |